文献速递病毒性肝炎

新生儿免疫下HBV母婴传播不一定是疫苗失败

Mother to Infant Transmission of Hepatitis B Virus in the Face of Neonatal Immunization Is Not Necessarily Primary Vaccine Failure.
PubMed 文献 · Clin Infect Dis · 2022-01-01

该研究回顾性分析HBV感染母亲所生婴儿的干血斑血清学标志物,并对免疫预防后仍感染HBV的新生儿血斑卡做分子分析。至少22%婴儿在宫内已感染,围产期感染占43%,宫内感染者均为野生型HBsAg且序列一致,围产期感染者常见HBsAg氨基酸改变。结论认为部分母婴传播源于宫内感染,现有产后预防可能无效,或需更早孕期抗病毒。

要点

  • 至少22%的母婴传播为宫内感染,现有产后预防可能无法阻断。
  • 围产期感染占43%,其HBsAg氨基酸改变常见且与母亲序列不同。
  • 宫内感染均为野生型HBsAg,新生儿与早期婴儿样本序列一致。

核心结论

  • 部分HBV母婴传播为宫内感染所致,并非疫苗失败。
  • 宫内感染可能对产后预防不敏感,当前孕期抗病毒推荐或为时过晚。

研究设计与样本

  • 回顾性分析HBV感染母亲所生婴儿干血斑的HBV血清学标志物。
  • 对免疫预防后仍感染HBV的新生儿血斑卡进行分子分析。

主要发现

  • 至少22%婴儿在宫内已感染HBV。
  • 围产期感染占43%。
  • 宫内感染者均为野生型HBsAg,新生儿与早期婴儿样本序列一致。
  • 围产期感染者中80%序列存在HBsAg氨基酸改变,且与母亲样本不同。

临床怎么用

  • 应认识到部分母婴传播为宫内感染,产后预防可能无法阻断。
  • 可考虑更早孕期使用抗病毒药物以降低宫内传播风险。
  • 仍需完成免疫程序以降低围产期HBV传播风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Surveillance programs undertaken in infants born to mothers with hepatitis B virus (HBV) provide an opportunity to analyze virological markers from the neonate and early infancy. These data inform on mechanisms of HBV transmission and how available interventions can be better used for control of HBV infections arising at the mother/child interface. METHODS: Retrospective analysis of HBV serological markers was undertaken in dried blood spots collected from infants born to mothers infected with HBV. In addition, molecular analysis was performed in newborn blood spot cards, collected after birth, from infants identified as infected with HBV despite receiving prophylaxis. RESULTS: Perinatal exposure could not account for all transmissions, with at least one-quarter (22%) of infants already infected in utero. All harbored a wild-type hepatitis B surface antigen (HBsAg), with identical sequences noted in the neonatal and early infancy samples. In contrast, in infants infected perinatally (43%), selection of viruses harboring amino acid changes in the HBsAg were common (80% of sequences) and divergent from the linked maternal sample. CONCLUSION: Currently considered to represent vaccine failure, it is likely that a proportion of HBV infections result from in utero acquisition. These infections are unlikely to be susceptible to postnatal prophylaxis, and current recommendations for maternal antiviral treatment may be too late to prevent transmission. Consideration should be given to the earlier use of antivirals during gestation to reduce the risk of intrauterine transmission together with completion of the immunization schedule also to reduce the perinatal risk of HBV transmission.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Ijaz S, Derrick J, Shute J, et al. Mother to Infant Transmission of Hepatitis B Virus in the Face of Neonatal Immunization Is Not Necessarily Primary Vaccine Failure. Clin Infect Dis. 2022. PMID: 34251456. doi:10.1093/cid/ciab622

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。